Brain Targeting of Duloxetine HCL via Intranasal Delivery of Loaded Cubosomal Gel: In vitro Characterization, ex vivo Permeation, and in vivo Biodistribution Studies

PURPOSE: Duloxetine (DLX) is dual serotonin and norepinephrine reuptake inhibitor suffering from limited bioavailability (≈ 40%) due to extensive hepatic metabolism. This work aims to formulate and evaluate DLX intranasal thermoreversible cubosomal gels to enhance its bioavailability and ensure effi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Int J Nanomedicine
Asıl Yazarlar: Elsenosy, Fatma Mohamed, Abdelbary, Ghada Ahmed, Elshafeey, Ahmed Hassen, Elsayed, Ibrahim, Fares, Ahmed Roshdy
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Dove 2020
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7732760/
https://ncbi.nlm.nih.gov/pubmed/33324051
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/IJN.S277352
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller